The American Association for Cancer Research is inviting applications for its AACR Clinical Oncology Research (CORE) Training Fellowships program.
The program is designed to provide future academic clinicians with an effective industry-academic practicum and a unique training opportunity in drug development. To that end, grants of up to $100,000 will be awarded to support a fellow’s work on site at the facility of one of AACR’s pharmaceutical industry partners. Time to be spent at the industry site over the one-year period may be flexible and is determined upon mutual agreement between the selected fellow, the fellow’s institution, and the industry partner. Indirect costs for up to a maximum of 20 percent of total direct costs are permitted.
The industry partners for this program and their research areas include the following:
AstraZeneca (facility located in Gaithersburg, Maryland) — Early-stage and late-stage clinical development in immuno-oncology.
Bayer Healthcare (facility located in Cambridge, Massachusetts) — Early-stage and/or late-stage clinical development in oncology.
To be eligible, applicants must have a medical degree (MD, DO, or MD/PhD) and not currently be a candidate for a further doctoral degree; have enrolled in an accredited hematology/oncology or radiation oncology fellowship program at an academic, medical, or research institution in the United States; and not be an employee or subcontractor of a U.S. government entity or for-profit private industry or a clinical fellow applying from a U.S. government laboratory (e.g., NIH, CDC, FDA, etc.).
See the American Association for Cancer Research website for complete program guidelines and application instructions.